Nuvation Bio Inc. (NUVB) stock
NUVBNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30107% above fair value
$3.90+0.06 (+1.56%)
Close on Nov 17, 2026Market cap $1.37BP/E –Yield –
Nuvation Bio market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Nuvation Bio's market cap was $1.49B on Nov 11, 2026, against $2.71B a year earlier. Over the last 5 years it ranged from $210.93M to $3.03B, with a median of $760.14M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.49B | -50.9% |
| 2025 | Dec 31, 2025 | $3.03B | +238.4% |
| 2024 | Dec 31, 2024 | $894.42M | +170.5% |
| 2023 | Dec 29, 2023 | $330.61M | -21.2% |
| 2022 | Dec 30, 2022 | $419.31M | -77.3% |
| 2021 | Dec 31, 2021 | $1.85B | – |
See a number that looks wrong?